Clinical Study
Long Term Survival Analysis of Hepatectomy for Neuroendocrine Tumour Liver Metastases
Table 1
Demographic data of patients before hepatectomy.
| Variables | () |
| Sex (M : F) | 7 : 5 | Age (median (range))-liver resection | 48.5 (20–71) | HBsAg positive | 2 (16.7%) | Serum bilirubin level (umol/L) | 8.5 (4–22) | Serum AST | 30 (17–203) | Serum ALT | 28 (16–65) | INR | 1 (0.9–1.2) | Albumin (g/L) | 41 (35–46) | PT (second) | 12.1 (10.2–14.9) | Creatinine level (umol/L) | 80 (58–131) | Hemoglobin level (g/dL) | 12.6 (9.3–14.9) | No. of patients with comorbid disease(s) | 5 (41.7%) | (i) Cardiovascular disease | 9 (75%) | (ii) Pulmonary disease | 1 (8.3%) | (iii) Renal impairment | 0 (0%) | (iv) Diabetes mellitus | 2 (16.7%) | (v) Grave disease | 1 (8.3%) |
|
|